GlassScriptPhysician profile
Caren T Hoffman
NPI 1790015881
$2,900.20
in general payments reported to CMS, 2019-2025
28 companies · $734 in 2025
The $734 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $156 · 2021: $148 · 2022: $772 · 2023: $441 · 2024: $261 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $574.02 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $441.19 | 2021-2025 | |
| Novo Nordisk INC | $210.64 | 2022-2025 | Wegovy |
| Exeltis, USA INC. | $203.27 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $171.93 | 2019-2024 | |
| Astellas Pharma US INC | $159.17 | 2024-2025 | Veozah |
| Aspira Women'S Health INC | $123.23 | 2019-2024 | Ova1 |
| Sumitomo Pharma America, INC. | $115.19 | 2023-2025 | Gemtesa, Myfembree |
| Allergan, INC. | $113.48 | 2019-2020 | |
| Sage Therapeutics, LLC | $90.85 | 2025 | Zurzuvae |
| Pfizer INC. | $65.70 | 2023-2025 | |
| Coopersurgical, INC. | $63.74 | 2019-2025 | |
| Myovant Sciences INC. | $62.03 | 2022 | |
| Amag Pharmaceuticals, INC. | $51.28 | 2019-2020 | |
| Scynexis, INC. | $46.96 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $45.24 | 2022-2024 | Aptima |
| Baxter Healthcare | $42.42 | 2023 | Perclot |
| Millicent US INC | $39.86 | 2025 | Intrarosa, Femlyv |
| Evofem Biosciences, INC. | $39.82 | 2021-2024 | |
| Therapeuticsmd, INC. | $39.74 | 2020-2022 | |
| Minerva Surgical, INC | $38.12 | 2023 | |
| Mycovia Pharmaceuticals, INC. | $34.37 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $32.61 | 2019-2020 | |
| Dexcom, INC. | $24.81 | 2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $24.11 | 2022 | |
| Agile Therapeutics, INC. | $19.54 | 2022 | |
| Genzyme Corporation | $17.46 | 2019 | |
| Channel Medsystems, INC. | $9.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caren Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.